AI assistant
LB PHARMACEUTICALS INC — Director's Dealing 2025
Sep 11, 2025
33183_dirs_2025-09-10_bdf047e0-cc15-4a63-890a-6c533f59d956.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LB PHARMACEUTICALS INC (LBRX)
CIK: 0001691082
Period of Report: 2025-09-10
Reporting Person: Turner Heather D (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $41.84 | 2034-11-17 | Common Stock (175706) | Direct | |
| Employee Stock Option (Right to Buy) | $41.84 | 2035-01-13 | Common Stock (7857) | Direct |
Footnotes
F1: One fourth (1/4) of the shares subject to the option award shall vest on November 18, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F2: One fourth (1/4) of the shares subject to the option award shall vest on November 18, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.